Lipoprotein-associated phospholipase A(2) activity and mass in relation to vascular disease and nonvascular mortality

Podobne zapisy

• Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality.
  od: Heart Protection Study Collaborative Group
  Wydane: (2010)
• Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
  od: Erqou, S, i wsp.
  Wydane: (2009)
• The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
  od: Kent, S, i wsp.
  Wydane: (2016)
• Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
  od: Thompson, A, i wsp.
  Wydane: (2010)
• Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.
  od: Parish, S, i wsp.
  Wydane: (2012)